Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-8002.58	-21561.30	-266.10
Graham Fair Price	-73.28	1.46	5.46
PEG	1781.71	6.93	0.37
Price/Book	-29.67	2.79	3.96
Price/Cash Flow	1188.66	-4740.37	367.85
Prices/Earnings	-882.10	-643.37	-65.51
Price/Sales	-42.70	29.86	52.11
Price/FCF	1188.66	-4740.37	367.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	159.39	0.21	0.08
Operating Margin	90.50	-0.03	-0.27
ROA	93.35	< 0.005	-0.01
ROE	-0.02	< 0.005	92.84
ROIC	-0.02	< 0.005	94.21
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.37	1.77	-79.17
Dividends QOQ	1.71	2.38	38.75
EBIT QOQ	-2.07	0.88	-57.25
EPS QOQ	-1.78	0.93	-47.81
FCF QOQ	1.16	-1.05	-8.73
Revenue QOQ	-0.31	0.23	-27.58
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	98.00	83.25	-15.05
Days Sales Outstanding (DSO)	479.41	422.32	-11.91
Inventory Turnover	0.92	1.08	17.72
Debt/Capitalization	0.06	0.04	-35.36
Quick Ratio	3.02	2.36	-21.82
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9.36	9.35	-0.15
Cash	1.53	1.64	7.03
Capex	0.08	-0.43	430.48
Free Cash Flow	0.10	< 0.005	-94.55
Revenue	0.71	0.87	22.55
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.46	2.69	-22.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.60	997.22	15000.41
Naive Interpretation	Member

06 - Financial Health · Bad

Rating